Trial intelligence / Profile preview

Effect of Burst-suppression-pattern in EEG on Generating Somatosensory Evoked Potentials

NCT02394002Unknown

Start
Mar 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of propofol (3 arms). Primary endpoint: Somatosensory Evoked Potential amplitude at 2 hours. Status: unknown.

02

Drugs

propofol

Beyond the preview

Go deeper on NCT02394002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02394002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call